In a search for potential drug candidates for combating COVID-19: computational study revealed salvianolic acid B as a potential therapeutic targeting 3CLpro and spike proteins
- PMID: 33928870
- DOI: 10.1080/07391102.2021.1918256
In a search for potential drug candidates for combating COVID-19: computational study revealed salvianolic acid B as a potential therapeutic targeting 3CLpro and spike proteins
Abstract
The global prevalence of COVID-19 disease and the overwhelming increase in death toll urge scientists to discover new effective drugs. Although the drug discovery process is a challenging and time-consuming, fortunately, the plant kingdom was found to have many active therapeutics possessing broad-spectrum antiviral activity including those candidates active against severe acute respiratory syndrome coronaviruses (SARS-CoV). Herein, nine traditional Chinese medicinal plant constituents from different origins (Glycyrrhizin 1, Lycorine 2, Puerarin 3, Daidzein 4, Daidzin 5, Salvianolic acid B 6, Dihydrotanshinone I 7, Tanshinone I 8, Tanshinone IIa 9) previously reported to exhibit antiviral activity against SARS-CoV were virtually screened in silico (molecular docking) as potential inhibitors of SARS-CoV-2 target proteins. The tested medicinal plant compounds were in silico screened for their activity against two key SARS-CoV-2 target proteins; 3CLpro, and Spike binding-domain proteins. Among the tested medicinal plant compounds, Salvianolic acid B 6 (Sal-B) showed promising binding affinities against the two specified SARS-CoV-2 target proteins compared to the reference standards used. Hence molecular dynamics simulations followed by calculating the free-binding energy were carried out for Sal-B providing information on its affinity, stability, and thermodynamic behavior within the two SARS-CoV-2 target proteins as well as key ligand-protein binding aspects. Besides, the quantum mechanical calculations showed that Sal-B can adopt different conformations due to the existence of various rotatable bonds. Therefore, the enhanced antiviral activity of Sal-B among other studied compounds can be also attributed to the structural flexibility of Sal-B. Our study gives an explanation of the structure activity relationship required for targeting SARS-CoV-2 3CLpro and Spike proteins and also facilitates the future design and synthesis of new potential drugs exhibiting better affinity and specificity. Besides, an ADME study was carried out on screened compounds and reference controls revealing their pharmacokinetics properties.Communicated by Ramaswamy H. Sarma.
Keywords: COVID-19; DFT calculations; Medicinal plants; Molecular docking; Molecular dynamics; drug repurposing.
Similar articles
-
Computational Search for Potential COVID-19 Drugs from Ayurvedic Medicinal Plants to Identify Potential Inhibitors against SARS-CoV-2 Targets.Curr Comput Aided Drug Des. 2023;19(1):51-67. doi: 10.2174/1573409919666221117145404. Curr Comput Aided Drug Des. 2023. PMID: 36424783
-
Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies.J Biomol Struct Dyn. 2023 Aug-Sep;41(13):5915-5945. doi: 10.1080/07391102.2022.2098821. Epub 2022 Jul 18. J Biomol Struct Dyn. 2023. PMID: 35848354
-
Computational identification of potential inhibitory compounds in Indian medicinal and aromatic plant species against major pathogenicity determinants of SARS-CoV-2.J Biomol Struct Dyn. 2022;40(24):14096-14114. doi: 10.1080/07391102.2021.2000500. Epub 2021 Nov 12. J Biomol Struct Dyn. 2022. PMID: 34766880
-
Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).Curr Pharm Des. 2021;27(38):3996-4007. doi: 10.2174/1381612827666210705160130. Curr Pharm Des. 2021. PMID: 34225607 Review.
-
Molecular scaffolds from mother nature as possible lead compounds in drug design and discovery against coronaviruses: A landscape analysis of published literature and molecular docking studies.Microb Pathog. 2021 Aug;157:104933. doi: 10.1016/j.micpath.2021.104933. Epub 2021 May 11. Microb Pathog. 2021. PMID: 33984466 Free PMC article. Review.
Cited by
-
Quinazolines and thiazolidine-2,4-dions as SARS-CoV-2 inhibitors: repurposing, in silico molecular docking and dynamics simulation.RSC Adv. 2024 Apr 23;14(19):13237-13250. doi: 10.1039/d4ra02029d. eCollection 2024 Apr 22. RSC Adv. 2024. PMID: 38655479 Free PMC article.
-
SAR, Molecular Docking and Molecular Dynamic Simulation of Natural Inhibitors against SARS-CoV-2 Mpro Spike Protein.Molecules. 2024 Mar 4;29(5):1144. doi: 10.3390/molecules29051144. Molecules. 2024. PMID: 38474656 Free PMC article.
-
Partnering essential oils with antibiotics: proven therapies against bovine Staphylococcus aureus mastitis.Front Cell Infect Microbiol. 2023 Sep 15;13:1265027. doi: 10.3389/fcimb.2023.1265027. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37790910 Free PMC article.
-
Salvianolic Acid B: A Review of Pharmacological Effects, Safety, Combination Therapy, New Dosage Forms, and Novel Drug Delivery Routes.Pharmaceutics. 2023 Aug 29;15(9):2235. doi: 10.3390/pharmaceutics15092235. Pharmaceutics. 2023. PMID: 37765204 Free PMC article. Review.
-
Design and Synthesis of Novel 5-((3-(Trifluoromethyl)piperidin-1-yl)sulfonyl)indoline-2,3-dione Derivatives as Promising Antiviral Agents: In Vitro, In Silico, and Structure-Activity Relationship Studies.Pharmaceuticals (Basel). 2023 Sep 4;16(9):1247. doi: 10.3390/ph16091247. Pharmaceuticals (Basel). 2023. PMID: 37765055 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous